R

Rebecca Lock

Akebia Therapeutics (United States)

35 papers and 1.7k citations.

PubIndex Score12Top 88% · mid-careerHow it's scored

35Publications

1.7kTotal Citations

First publication: 1986First senior author: 2012

Top publicationsby citations

Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers

Rebecca Lock, Karen Cichowski|Journal of Clinical Investigation|2016

Cited by 43

Indexing the rest of 35 publications…